Treatment of idiopathic nephrosis by immunophillin modulation

Nephrology Dialysis Transplantation

Volumn 18, Issue SUPPL. 6, 2003, Pages

  Meyrier, Alain ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Adults; Children; Cyclosporine; Focal segmental glomerulosclerosis; Idiopathic; Immunophillin modulation; Minimal change disease; Nephrosis; Nephrotic syndrome; Rapamycin; Sirolimus; Tacrolimus; Treatment

Indexed keywords

ALKYLATING AGENT; CHLORAMBUCIL; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; GLUCOCORTICOID; IMMUNOPHILIN; PLACEBO; PREDNISOLONE; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS;

ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG FORMULATION; DRUG PROTEIN BINDING; DRUG RESPONSE; FOCAL GLOMERULOSCLEROSIS; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROSIS; NEPHROTOXICITY; PRIORITY JOURNAL; REMISSION; STEROID THERAPY;

CYCLOSPORINE; HUMANS; IMMUNOPHILINS; IMMUNOSUPPRESSIVE AGENTS; NEPHROSIS; SIROLIMUS; TACROLIMUS;

EID: 0041382455     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Winn MP. Approach to the evaluation of heritable diseases and update on familial focal segmental glumerulosclerosis. Nephrol Dial Transplant 2003; 18 [Suppl 6]: vi14-vi20
2. Brenchley PEC. Vascular permeability factors in steroid-sensitive nephrotic syndrome and focal segmental glomerulosclerosis. Nephrol Dial Transplant 2003; 18 [Suppl 6]: vi21-vi25
3. Mathieson PW. Immune dysregulation in minimal change nephropathy. Nephrol Dial Transplant 2003; 18 [Suppl 6]: vi26-vi29
4. Suthanthiran M, Morris RE, Strom TB. Immunosuppressants: cellular and molecular mechanisms of action. Am J Kidney Dis 1996; 28: 159-172
5. Liu J. FK506 and cyclosporin: molecular probes for studying extracellular signal transduction. Trends Pharmacol Sci 1993; 14: 182-188
6. Camardo JS, Scarola JA, Maida BT. Rapamycin (sirolimus, rapamune). Curr Opin Nephrol Hypertens 1995; 4: 482-487
7. Molnar-kimber KL. Mechanism of action of rapamycin (sirolimus, rapamune). Transplant Proc 1996; 28: 964-969
8. Kelly PA, Gruber SA, Behbod R, Kahan B. Sirolimus, a new, potent immunosuppressive agent. Pharmacotherapy 1997; 17: 1148-1156
9. Meyrier A. Antiproteinuric and immunologic effects of cyclosporin A in the treatment of glomerular diseases. Nephrol Dial Transplant 1992; 7: 80-84
10. Meyrier A. Use of cyclosporin in the treatment of idiopathic nephrotic syndrome in adults. In: Tejani A, ed. Cyclosporin in the Therapy of Renal Disease. Karger, Basel: 1995: 28-48
11. Zietse R, Wenting GJ, Kramer P, Schalekamp MADH, Weimar W. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome. Clin Sci 1992; 82: 641-650
12. Berden JHM, Schrijver G, Assmann KJM, Koene RAP. Antiproteinuric effect of cyclosporin (CsA) in anti-GBM nephritis in the mouse. Proceedings of the 2nd Congress on Immunointervention in Autoimmune Diseases. Paris: 1991: 185
13. Desassis JF, Raats CJI, Bakker MAH, van den Born J, Berden JHM. Antiproteinuric effect of ciclosporin A in adriamycin nephropathy in rats. Nephron 1997; 75: 336-341
14. Meyrier A, Noël LH, Auriche P, Callard P. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Kidney Int 1994; 45: 1446-1456
15. Niaudet P, Broyer M, Habib R. Serial renal biopsies in children with idiopathic nephrosis receiving cyclosporin. In: Tejani A, ed. Cyclosporin in the Therapy of Renal Disease. Karger, Basel: 1995: 78-83
16. Tejani A, Butt K, Trachtman H et al. Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int 1988; 33: 729-734
17. McCauley J, Shapiro R, Ellis D et al. Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 1993; 8: 1286-1290
18. Hoyer PF, Krull F, Brodehl J. CsA in frequently relapsing minimal-change nephrotic syndrome. Lancet 1986; 2: 335
19. Lagrue G, Laurent J, Belghiti D, Robeva R. Cyclosporine A and idiopathic nephrotic syndrome. Lancet 1986; 2: 692-693
20. Meyrier A, Simon P, Perret G, Condamin MC. CsA in lipoid nephrosis and focal-segmental hyalinosis resistant to other treatments. Proceedings of the 18th Annual Meeting of the American Society of Nephrology. 1995; 48A (abstract)
21. Meyrier A, Simon P, Perret G, Condamin-Meyrier MC. Remission of idiopathic nephrotic syndrome after treatment with cyclosporine A. Br Med J 1986; 292: 789-792
22. Collaborative Study Group of Sandimmun in Nephrotic Syndrome Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Clin Nephrol 1991; 35 [Suppl 1]: S48-S60
23. Meyrier A, Niaudet P, Brodehl J. Optimal Use of Sandimmun in Nephrotic Syndrome. Springer-Verlag, Berlin: 1992: 1-34
24. Niaudet P, Habib R, Cyclosporine in the treatment of idiopathic nephrosis. J Am Soc Nephrol 1994; 5: 1049-1056
25. Habib R, Niaudet P. Comparison between pre and posttreatment renal biopsies in children receiving ciclosporine for idiopathic nephrosis. Clin Nephrol 1994; 42: 141-146
26. Garin EH, Orak JK, Hiott KL. Sutherland SE Cyclosporine therapy for steroid-resistant nephrotic syndrome. A controlled study. Am J Dis Child 1988; 142: 985-988
27. Tejani A, Suthanthiran M, Pomerantz A. A randomized controlled trial of low-dose prednisone and ciclosporine versus high-dose prednisone in nephrotic syndrome of children. Nephron 1991; 59: 96-99
28. Niaudet P, French Society of Pediatric Nephrology. Comparison of cyclosporine and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicenter randomized controlled trial. Pediatr Nephrol 1992; 6: 1-3
29. Ponticelli C, Edefonti A, Ghio L et al. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant 1993; 8: 1326-1332
30. Ponticelli C, Rizzoni G, Edefonti A et al. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 1993; 43: 1377-1384
31. Lieberman KV, Tejani A. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 1996; 7: 56-63
32. Cattran DC, Appel GB, Hebert LA et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int 1999; 56: 2220-2226
33. Schweda F, Liebl R, Riegger GAJ, Krämer BK. Tacrolimus treatment for steroid- and cyclosporin- resistant minimal-change nephrotic syndrome. Nephrol Dial Transplant 1997; 12: 2433-2435
34. Peraldi MN, Morelon E, Mamzer-Brunel MF, Burke J, Kreis H. Renal function and pathology after switch from calcineurin-dependent drugs to sirolimus in renal transplant recipients with chronic graft nephropathy. J Am Soc Nephrol 2000; 11: 702A (abstract A3694)
35. Niaudet P, Reigneau O, Humbert H. A pharmacokinetic study of Neoral in childhood steroid-dependent nephrotic syndrome. Pediatr Nephrol 2001; 16: 154-155
36. Matsumoto H, Nakao T, Okada T et al. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults. Clin Nephrol 2001; 55: 143-148